Abivax (ABVX) Change in Receivables (2024 - 2026)
Abivax (ABVX) posted quarterly Change in Receivables of -$4.1 million for Q1 2026, down 79.44% year-over-year from -$19.8 million in Q1 2025, and down 137.5% quarter-over-quarter from $10.9 million in Q4 2025.
Abivax (ABVX) Change in Receivables (2024 - 2026) Analysis & Trends
Abivax's Change in Receivables history runs 3 years deep, the most recent figure standing at -$4.1 million for Q1 2026.
- In Q1 2026, Change in Receivables fell 79.44% year-over-year to -$4.1 million; the TTM figure through Mar 2026 stood at $6.5 million (up 95.03% YoY), while the FY2025 annual figure was $8.2 million, up 67.09% from the prior year.
- Change in Receivables for Q1 2026 stood at -$4.1 million, down from $10.9 million in the prior quarter.
- The five-year high for Change in Receivables was $10.9 million in Q4 2025, with the low at -$5.4 million in Q3 2025.
- The 3-year median for Change in Receivables is -$735466.9 (2024), against an average of $1.0 million.
- Peak annual rise in Change in Receivables reached 215.48% in 2025, while the deepest fall reached 209.07% in 2025.
- Abivax's Change in Receivables stood at $3.4 million in 2024, then surged by 215.48% to $10.9 million in 2025, then plunged by 137.5% to -$4.1 million in 2026.
- Business Quant data shows ABVX's Change in Receivables at -$4.1 million in Q1 2026, $10.9 million in Q4 2025, and -$5.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | -4.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.08 Mn |
| Mar 31, 2026 | -4.08 Mn |
| Dec 31, 2025 | 10.88 Mn |
| Dec 31, 2025 | 10.88 Mn |
| Sep 30, 2025 | -5.36 Mn |
| Sep 30, 2025 | -5.36 Mn |
| Jun 30, 2025 | 5.03 Mn |
| Jun 30, 2025 | 5.03 Mn |
| Mar 31, 2025 | -2.27 Mn |
| Mar 31, 2025 | -2.27 Mn |
| Dec 31, 2024 | 3.45 Mn |
| Dec 31, 2024 | 3.45 Mn |
| Sep 30, 2024 | -2.92 Mn |
| Sep 30, 2024 | -2.92 Mn |
| Jun 30, 2024 | 5.06 Mn |
| Jun 30, 2024 | 5.06 Mn |
| Mar 31, 2024 | -735,466.92 |
| Mar 31, 2024 | -735,466.92 |